Pirox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pirox

Property Description
Active ingredient Piroxicam
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Symptomatic relief of pain, swelling, and inflammation
Forms Oral capsule, Oral tablet, Topical gel, Parenteral solution
Origin Synthetic compound (Oxicam derivative)

Pirox is a synthetic medicinal product primarily used for its capacity to reduce symptoms of inflammation, pain, and stiffness. Its identity is defined by its single active ingredient, Piroxicam, which places it within the high-level pharmacological classification of a Nonsteroidal Anti-inflammatory Drug (NSAID). This identity means Pirox addresses symptoms by directly engaging with the body's inflammatory response.


What Type of Medicine is Pirox and Its Core Identity?

Pirox is a single-component drug whose core purpose is to alleviate physical discomfort stemming from chronic inflammatory processes. The active substance, Piroxicam, functions as a non-selective inhibitor of the cyclooxygenase (COX) enzyme system, a mechanism foundational to the entire NSAID class. Understanding this class is crucial, as it denotes the drug's capacity to modify the biological cascade that produces pain- and inflammation-inducing prostaglandins. As a member of the oxicam family, Piroxicam is distinctly characterized by a long plasma half-life, a property that facilitates convenient once-daily administration in many forms.


Piroxicam's Composition and Available Forms

The medicinal entity Pirox is a monotherapy, meaning its therapeutic action is attributable solely to the Piroxicam active ingredient, combined with standard pharmaceutical excipients. The medication is manufactured in several distinct dosage forms to accommodate patient needs, including oral capsules, oral tablets, and formulations for localized treatment such as topical gels or parenteral solutions for injection. These forms determine the applicable route of administration, which can be oral, topical, or parenteral. The availability of the gel formulation, for example, is intended for local application to target pain and swelling in a confined area, as opposed to systemic treatment.


General Purpose: Relief from Inflammation, Pain, and Stiffness

The general purpose of Piroxicam is centered on providing relief from the three chief symptoms associated with inflammatory conditions: persistent pain, surrounding swelling, and joint or tissue stiffness. This symptomatic relief is achieved by interfering with the chemical production of inflammatory mediators at the cellular level. Piroxicam acts to reduce the visible and palpable signs of inflammation. By reducing these core symptoms, Piroxicam serves to improve overall physical comfort and function.

Regulatory References

  1. COX-Inhibitors - StatPearls

What side effects are possible with Pirox?

Possible Side Effects and Safety Information: Piroxicam

Piroxicam’s official safety profile, as defined by regulatory bodies, emphasizes the potential for serious systemic risks.

Key Safety Warnings and Restrictions

Regulatory documents include strong warnings regarding two major, potentially fatal risks:

  • Serious Gastrointestinal (GI) Events: Increased risk of stomach or intestinal bleeding, ulceration, and perforation, which can occur at any time without warning.
  • Serious Cardiovascular Thrombotic Events: Increased risk of blood clot-related events, including Myocardial Infarction (Heart Attack) and Stroke.

To mitigate these risks, regulatory agencies mandate that Piroxicam be used at the lowest effective dose for the shortest duration necessary.

Serious Adverse Reactions and Contraindications

Serious Adverse Reactions also documented include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), severe liver injury (hepatitis/jaundice), acute renal failure, and severe heart failure. SCARs often occur early in therapy.

Contraindications (situations where the drug must not be used) include severe heart, kidney, or liver failure; the third trimester of pregnancy; history of recurrent GI bleeding/ulcers; and the setting of coronary artery bypass graft (CABG) surgery.

Frequency-Classified Effects

Classification Examples of Documented Effects
Common Nausea, vomiting, abdominal discomfort, diarrhea, headache, dizziness, edema, rash.
Rare/Very Rare Anemia, anaphylaxis, hypertension, blurred vision, aseptic meningitis, and blood disorders.

Population Note: Elderly patients are at a greater risk for serious GI and renal adverse effects.

Overdose and Emergency Response

The official regulatory documentation for Piroxicam describes a range of documented manifestations that may occur following an overdose, primarily affecting the gastrointestinal and central nervous systems. Initial signs often include nausea, vomiting, epigastric pain, headache, drowsiness, dizziness, and ringing in the ears (tinnitus).

Overdosage carries the potential for severe or life-threatening outcomes, including acute renal failure, respiratory depression, seizures, and a severely decreased level of consciousness leading to coma. Critical gastrointestinal events, such as severe hemorrhage indicated by bloody or black, tarry stools, are also officially documented risks. Elderly patients and individuals with pre-existing kidney or liver impairment are noted to be at increased risk for these serious effects.

Because no specific antidote is known for Piroxicam, immediate action and specialized medical intervention are required. Regulatory authorities state that individuals must seek emergency medical attention immediately and contact a poison control center if an overdose is suspected. Management in a hospital setting is symptomatic and supportive, focusing on procedures like administering activated charcoal or performing gastric lavage. Close monitoring of vital signs, as well as renal and hepatic function, is required during observation.

Therapeutic Uses of Pirox

Pirox is commonly used in situations involving certain distressing symptoms from chronic inflammatory conditions. It is considered relevant for managing symptoms that interfere with daily comfort in patients with joint disorders.

Management and Relief of Inflammatory Symptoms

The medication is commonly used across conditions presenting with chronic manifestations like Osteoarthritis, Rheumatoid Arthritis, and relevant episodic manifestations such as Acute Gout. It helps address symptom clusters that may become intense or disruptive, such as persistent joint swelling and stiffness. In these contexts, Pirox supports the patient during difficult episodes by contributing to easing the overall symptom load and may assist with maintaining functional stability.

The medication is generally applied in clinical settings that involve acute or unstable symptom patterns, such as flare-ups of chronic conditions. It is relevant when supportive symptom management is appropriate for symptoms associated with acute or episodic changes.

“Pirox is generally applied in situations where additional symptomatic support is needed.”

It is often used during phases when symptoms become more noticeable, and the medication supports general well-being during symptomatic phases.


Quick Fact: Relief for Stiffness

Pirox is considered relevant for managing symptoms related to joint stiffness, especially the characteristic morning stiffness, which is a symptom that creates noticeable functional strain.

Regulatory References

  1. DailyMed (NIH/NLM) for Piroxicam capsules

Eligibility and Restrictions for Use

Who can and cannot use Pirox?

Pirox (Piroxicam) eligibility is strictly defined by regulatory guidelines, primarily covering adults seeking symptomatic relief for conditions like Osteoarthritis and Rheumatoid Arthritis. The medicine is not typically recommended as a first-line treatment for acute issues.


Populations Who Must Not Use Pirox (Contraindications)

Individuals are prohibited from using Pirox if they have:

  • A known allergy or hypersensitivity to Piroxicam, aspirin, or other NSAIDs.
  • A current or history of gastrointestinal ulceration, bleeding, or perforation.
  • Severe heart failure or severe hepatic/renal failure.
  • Need for pain relief in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Reached the third trimester of pregnancy (from 30 weeks gestation).
  • Are taking concomitant anticoagulants or other NSAIDs.

Restricted or Conditional Use

Use of Pirox requires caution and benefit-risk assessment in certain groups:

  • Elderly Patients (over 65/70): Patients over 80 years old should generally avoid use due to significantly increased risk of serious gastrointestinal complications.
  • Organ Impairment: Patients with mild-to-moderate renal or hepatic impairment require close monitoring and caution.
  • Reproductive Status: The drug is not recommended for women who are nursing/breastfeeding or those attempting to conceive.
  • Pediatric Patients: Use is not recommended for children under 12 years of age, though some jurisdictions define use for Juvenile Rheumatoid Arthritis.

What should I know about interactions with other medicines?

Pirox (piroxicam) is a non-steroidal anti-inflammatory drug (NSAID) and may interact with a wide range of other medications, increasing the risk of adverse effects or changing the effectiveness of one or both drugs. It is crucial to inform your healthcare provider about all prescription and non-prescription medicines, vitamins, and herbal supplements you are currently taking.

Major Interactions

Co-administration of Pirox with certain medicines is highly discouraged due to the risk of serious complications. These include:

  • Other NSAIDs or Aspirin: Concurrent use significantly increases the risk of gastrointestinal (GI) bleeding, ulceration, and other severe GI and systemic adverse events. This includes low-dose aspirin used for cardiovascular protection.
  • Anticoagulants ("Blood Thinners"): Drugs like warfarin, apixaban, or clopidogrel, when taken with Pirox, drastically increase the risk of serious or fatal bleeding.
  • Methotrexate: Pirox may elevate the concentration of methotrexate in the blood, leading to toxicity with potentially severe side effects.

Caution and Monitoring

Close monitoring or dose adjustment is required when Pirox is taken with the following groups of medicines, as interactions may reduce their effectiveness or increase toxicity:

Medicine Class Potential Interaction
Diuretics (e.g., furosemide) Pirox may lessen their ability to remove fluid, which can lead to swelling and kidney function issues.
Angiotensin-Converting Enzyme (ACE) Inhibitors/ARBs (for blood pressure) Pirox may decrease their blood pressure-lowering effect and can increase the risk of kidney impairment, especially in older patients or those with pre-existing kidney problems.
Lithium Pirox may increase lithium blood levels, raising the risk of toxicity.
Corticosteroids (e.g., prednisone) Increased risk of serious gastrointestinal bleeding and ulcers.
Selective Serotonin Reuptake Inhibitors (SSRIs) (for depression) Increased risk of bleeding.

It is also advised to avoid excessive alcohol consumption, as it can increase the risk of stomach irritation and bleeding when taking Pirox.

Mechanism of Action

The mechanism of action for Pirox is mediated by its single active ingredient, Piroxicam, which functions as a non-selective, competitive inhibitor of the Cyclooxygenase (COX) enzyme system. This action involves the molecule binding reversibly to the active sites of both COX-1 and COX-2 isoforms, blocking the access of the precursor molecule, arachidonic acid. This primary molecular event prevents the enzymatic conversion required for the synthesis of prostaglandins, which are lipid-based chemical messengers.

This inhibition translates into several system-level modulations. Peripherally, the reduction in pro-inflammatory prostaglandins (like PGE2) decreases the chemical sensitization of nociceptive signaling fibers and attenuates mediator influence on vascular permeability. Centrally, the inhibition of PGE2 synthesis within the hypothalamus affects the thermoregulatory pathway. This mechanism results in the adjustment of the core body temperature set-point, and the attenuation of physiological signaling associated with tissue disruption.

Dosage and Administration Information

The administration of Piroxicam (Pirox) involves standardized procedural steps for use.

Administration Scope

The medication is available in several dosage forms, primarily for oral (capsules and tablets) and topical/cutaneous (gel) administration. Oral forms are intended for systemic effects, while the topical gel is applied locally.

Instruction Rule
Route of administration Oral for systemic use; Topical/Cutaneous for localized use.
Dosing schedule For chronic conditions, the standard is 20 mg taken once daily. Some protocols permit a divided dose of 10 mg two times a day. The recommended maximum daily dose for chronic use is generally 20 mg.
Timing in relation to meals Oral administration is instructed to be taken with or immediately after food or a full glass of water.
Special procedural conditions Oral capsules/tablets must be swallowed whole and must not be crushed or chewed. The topical gel must be gently massaged into the skin, and no occlusive dressings should be used over the application site.
Age-group rules Lower doses should be considered for patients with impaired kidney function, and some guidelines provide weight-based dosing for pediatric use.

General Use Framework

The primary frequency pattern for systemic use is once daily, a schedule facilitated by the drug’s long plasma half-life. The governing principle is to use the lowest effective dose for the shortest duration necessary. Furthermore, the protocol requires that the therapeutic benefit and continued use must be reviewed within 14 days of initiating therapy.


The instructions establish a structured pattern for administering Piroxicam that governs the chosen delivery route, the standardized dosage quantity, and the required frequency. This protocol defines the precise conditions for intake and defines the time-dependent framework for its use.

Recent Clinical Evidence

Research evidence / Overview of studies for Pirox


Evidence from Studies for Osteoarthritis (OA)

Piroxicam was studied in the context of symptoms related to Osteoarthritis (OA), which is a condition characterized by functional limitations. The core evidence comes from Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. Researchers examined outcomes related to physical discomfort (pain severity) and the ability to perform daily functioning or activity level.

Studies monitored how symptoms evolved over defined time intervals. The findings describe patterns observed in the studies regarding measured differences in pain scores and functional mobility scores when Piroxicam was compared to a placebo or other anti-inflammatory medicines. This research contributes to understanding symptom patterns observed during short- to intermediate-term observation of OA. However, the follow-up durations were limited in many core efficacy trials, resulting in limited information for long-term outcomes regarding sustained symptomatic changes beyond six months.

Evidence from Studies for Rheumatoid Arthritis (RA)

Piroxicam was evaluated in studies focusing on symptoms of Rheumatoid Arthritis (RA). Research examined outcomes linked to inflammatory or irritative states, such as the number of swollen or tender joints, and the duration of characteristic morning stiffness. Data for certain groups remain insufficient. For instance, while some studies included patients with Juvenile Rheumatoid Arthritis (JIA), the evidence for this specific pediatric population is limited and often comes from smaller, older clinical trials.

Evidence from Studies for Acute Gout and Musculoskeletal Pain

Piroxicam was studied in research exploring short-term symptom changes associated with conditions characterized by episodic or acute manifestations, such as acute gouty arthritis and short-term musculoskeletal disorders. For acute gout, research focused on the measured outcomes related to physical discomfort and the resolution of other acute signs. Findings describe patterns related to measured symptom change during the acute, short-term episode. Because these conditions are often temporary or episodic, the research periods are naturally very short-term.

Key Studies & References

  1. Piroxicam Capsule Labeling Information (Indications, Clinical Pharmacology, Clinical Studies)
  2. Efficacy of piroxicam in the treatment of rheumatoid arthritis: a pooled analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Pirox (FAQ)


Q: How quickly does Pirox start to work?

A: Piroxicam has a relatively long elimination half-life, meaning it stays in the body for an extended period. While patients may feel some relief sooner, the time required to reach a stable level and full symptomatic effect for chronic conditions is often described in studies as taking up to two weeks.


Q: How long do the effects of Pirox typically last?

A: Piroxicam is distinguished by its long plasma half-life, which is approximately 38 to 50 hours. This characteristic is why the medication is commonly administered once per day, as the effects are sustained over a long duration.


Q: Is Pirox available over the counter, or is it prescription-only?

A: The systemic forms of Pirox, such as capsules and tablets, are typically classified as prescription-only medicines in most regions. This classification is primarily due to the potential for serious gastrointestinal and cardiovascular risks. Some lower-strength topical forms, like gels, may be available without a prescription depending on local regulations.


Q: Can Pirox be used long-term?

A: Regulatory guidelines emphasize that Pirox should be used at the lowest effective amount for the shortest duration necessary to manage symptoms. Long-term use of systemic forms may be associated with an increased risk of serious adverse events. For continued treatment, official documents state that use requires frequent medical review.


Q: What is the usual duration of treatment with Pirox?

A: For ongoing conditions, the official protocol mandates that a physician must review the clinical benefit and tolerability of Pirox within 14 days of starting treatment. Beyond this initial check, the duration is determined on a case-by-case basis under medical supervision, adhering to the shortest duration principle.


Q: How often is Pirox typically taken?

A: The most common and primary frequency pattern for Pirox is once daily, which is supported by its long half-life. However, some official labeling may permit a dose to be divided and taken twice a day.


Q: How does Pirox affect the liver?

A: The liver is the primary organ responsible for metabolizing Pirox before it is eliminated from the body. Official safety information documents rare but serious adverse reactions involving the liver, including severe liver injury or acute hepatic failure.


Q: How is Pirox eliminated from the body?

A: Pirox is primarily eliminated from the body after being broken down by the liver into inactive components. Less than 10% of the active drug is excreted unchanged, with the majority of the metabolized substances leaving the body through urine.


Q: What is Pirox intended to achieve in the body?

A: Pirox is intended to provide symptomatic relief from physical discomfort and functional limitations. It works to reduce pain, swelling, and stiffness that are associated with chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis.


Q: Is Pirox safe to take during pregnancy?

A: Pirox is strictly prohibited from use during the third trimester of pregnancy (from 30 weeks gestation). Use during the first and second trimesters is generally not recommended unless use is determined to be necessary based on an individual medical assessment.


Q: Can breastfeeding mothers use Pirox?

A: Official information advises against the use of Pirox while breastfeeding. The active ingredient, Piroxicam, is excreted into human breast milk, and there is a potential for adverse effects on the nursing infant.


Q: What are the signs of a severe allergic reaction to Pirox?

A: Serious adverse events, including anaphylaxis, are documented in official safety information. Signs of a severe reaction can include the development of a rash, swelling of the face, throat, or limbs, and the onset of breathing difficulties.


Q: What should I do if I forget to take my Pirox?

A: Official patient instructions state that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Two doses should not be taken together to make up for a missed dose.


Q: What is the difference between Pirox and other similar medicines?

A: Pirox belongs to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. Its active ingredient, Piroxicam, is characterized within its pharmacological class by a significantly longer plasma half-life compared to many other NSAIDs. This key pharmacological difference is what allows Pirox to be administered once daily for many uses.


Q: Are there different strengths of Pirox?

A: Yes, official drug product information describes Piroxicam as being available in different strengths across its various dosage forms. For instance, oral capsules and tablets are commonly available in both 10 mg and 20 mg strengths.


Q: Is there a list of common foods to avoid when taking Pirox?

A: Official warnings primarily focus on drug-to-drug interactions and avoiding alcohol due to the increased risk of gastrointestinal bleeding. There is no official list of common foods that must be avoided when using Pirox.


Q: What happens if I drink alcohol while taking Pirox?

A: Official guidance advises against consuming alcohol while taking Pirox. The co-administration of alcohol with NSAIDs significantly increases the risk of damaging the gastrointestinal lining, which can lead to bleeding and ulceration.


Q: Can Pirox affect sleep?

A: While regulatory safety information does not specifically list sleep changes, it does document the possibility of central nervous system effects, such as dizziness, headache, and somnolence (drowsiness). These effects may be related to changes in a patient's sleep pattern.


Q: Is it true that Pirox can make me sensitive to the sun?

A: Official product documentation lists photosensitivity, which is an increased sensitivity of the skin to sunlight, as a less common, though reported, side effect of Piroxicam. Official guidance often recommends exercising caution regarding sun exposure while using this product.


Q: Is Pirox commonly used in children?

A: Pirox is generally not recommended for use in children under 12 years of age. However, in specific cases, its use and weight-based dosing may be defined in certain jurisdictions for pediatric conditions like Juvenile Idiopathic Arthritis, when use is defined for specific conditions.


Q: Does Pirox cause weight gain?

A: Official safety documents report fluid retention, also known as edema, and swelling as possible side effects. While not strictly listed as 'weight gain,' these fluid changes can lead to an increase in weight. Serious adverse events related to fluid retention or swelling may be associated with heart or kidney issues, which are serious risks for NSAIDs.


Q: Can Pirox affect the results of lab tests?

A: Yes, regulatory information indicates that Piroxicam can affect the results of certain laboratory tests, including those for platelet function. For patients undergoing long-term therapy, official guidance notes the need for periodic monitoring of kidney and liver function and blood counts during long-term therapy.


Q: Can Pirox be used for menstrual pain?

A: Pirox is officially indicated for chronic conditions such as Osteoarthritis and Rheumatoid Arthritis. While Piroxicam has been examined in clinical studies for acute pain, including primary dysmenorrhea (menstrual pain), this specific use may not be included in all national therapeutic indications.


Q: Is it possible to become dependent on Pirox?

A: Piroxicam is a non-steroidal anti-inflammatory drug (NSAID), not an opioid. It is not classified as a controlled substance by regulatory bodies, and therefore, it does not carry a documented risk of dependence or abuse in its scheduling.


Q: Does Pirox have any known effect on fertility?

A: Official prescribing information indicates that the use of Pirox may impair female fertility. It is not recommended for women who are actively attempting to conceive. If a woman is experiencing difficulty conceiving or is undergoing infertility investigation, the possibility of discontinuing Pirox may be considered.


Q: Can Pirox be crushed or split?

A: The regulatory instructions for the oral forms (capsules and tablets) explicitly state that they must be swallowed whole. They must not be crushed, chewed, or split, as this could interfere with the way the drug is meant to be released and absorbed, potentially increasing the risk of gastrointestinal side effects.


Q: Is Pirox chemically similar to aspirin?

A: Piroxicam is chemically distinct from aspirin, though both belong to the broad class of NSAIDs. However, due to a recognized potential for cross-sensitivity, official contraindications advise that patients who have previously experienced severe allergic reactions to aspirin or other NSAIDs should not take Pirox.

How should Pirox be stored and disposed of?

Official Storage and Disposal Requirements

Piroxicam (Pirox) must be stored at Controlled Room Temperature, officially defined as 59 F to 86 F (15 C to 30 C). Regulatory documents explicitly state that the product must not be stored above 30 C.

To ensure stability and integrity, the medication must be protected from light and excess moisture, and the container must be kept tightly closed.

For child safety, Piroxicam must be stored out of the sight and reach of children.

Disposal of unused or expired Piroxicam is officially managed through drug take-back programs or mail-back services. The medication is not recommended for disposal by flushing. If take-back is unavailable, the official procedure is to mix the product with an undesirable substance, seal it in a container, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pirox found in:

A-Z Index: